Tag: Wockhardt
Wockhardt makes breakthrough in pneumonia treatment with Nafithromycin WCK 4873
Wockhardt is proud to announce the successful completion of its pivotal Phase 3 pneumonia study involving the macrolide antibiotic Nafithromycin WCK 4873. This significant achievement ... Read More
Wockhardt, Serum Life Sciences partner to manufacture vaccines in UK
Wockhardt Limited said that it has signed a collaboration agreement through its subsidiary with Serum Life Sciences Ltd, UK, which in turn is a subsidiary ... Read More
Wockhardt, RDIF strike deal with for Sputnik V and Sputnik Light vaccines
The Russian Direct Investment Fund (RDIF), the Russian sovereign wealth fund, has entered into a partnership with Indian pharma company Wockhardt Limited for producing and ... Read More